Introduction: Vaccination provides health and economic benefits to the individual and to society. In Saudi Arabia, public support for immunisation programmes is generally high and well received. However, the benefits of vaccines are often not fully known or appreciated. When public discussion on vaccine safety, quality or efficacy occurs, very often misinformation creeps into the debate through the internet and other media sources, significantly weakening immunisation programmes. Vaccine hesitancy is a concept frequently used in the discourse around vaccine acceptance. This study reflects on the factors associated with vaccine hesitancy, through a study focusing on knowledge, attitudes and beliefs among parents of young children. Methods: A cross-sectional study was carried out in seven primary schools in Makkah city, Saud Arabia. Data were collected in 2017 through a computer based-survey administered to 100 parents with children aged between 2 months and 17 years of age. Questionnaire responses were analysed using Minitab. Results: Many parents (with a total of 292 children) agreed on the importance of vaccinations, to protect their children’s health and to prevent the spread of diseases in the community. Most parents (68.7%, P < 0.05) reported their child had received all recommended vaccines. Approximately one third (31.3%, P < 0.05) of parents indicated their hesitation in having their child vaccinated. The lack of vaccines in primary care centres, fear of adverse events and vaccine safety were the reasons most frequently mentioned by these vaccine-hesitant parents. In addition, some parents believed vaccines had become a business and that profits were more important than their children’s safety. Other parents complained about the increasingly “crowded” vaccination schedules. A minority of parents believe that vaccines did not prevent the spread of disease in the community (P < 0.05). Discussion and Conclusions: Vaccine hesitancy is a common problem in Makkah, Saudi Arabia. Further research will be needed to better understand when, how and why these beliefs are formed.
References
[1]
Fombonne, E., Zakarian, R., Bennett, A., Meng, L. and McLean-Heywood, D. (2006) Pervasive Developmental Disorders in Montreal, Quebec, Canada: Prevalence and Links with Immunizations. Pediatrics, 118, e139-e150.
https://doi.org/10.1542/peds.2005-2993
[2]
WHO (2018).
http://www.who.int/immunization/monitoring_surveillance/data/sau.pdf
[3]
Posfay-Barbe, K.M., Heininger, U., Aebi, C., Desgrandchamps, D., Vaudaux, B. and Siegrist, C.A. (2005) How Do Physicians Immunize Their Own Children? Differences among Pediatricians and Nonpediatricians. Pediatrics, 116, e623-e633.
[4]
Verani, J., Baqui, A., Broome, C., Cherian, T., Cohen, C., et al. (2017) Case-Control Vaccine Effectiveness Studies: Preparation, Design, and Enrollment of Cases and Controls. Vaccine, 35, 3295-3302. https://doi.org/10.1016/j.vaccine.2017.04.037
[5]
Wakefield, A.J., Murch, S.H., Anthony, A., et al. (1998) Ileal-Lymphoid-Nodular Hyperplasia, Non-Specific Colitis, and Pervasive Developmental Disorder in Children. The Lancet, 351, 637-641. https://doi.org/10.1016/S0140-6736(97)11096-0
[6]
MacDonald, N. (2015) Vaccine Hesitancy: Definition, Scope and Determinants. Vaccine, 33, 4161-4164. https://doi.org/10.1016/j.vaccine.2015.04.036
[7]
Miller, E. (2015) Controversies and Challenges of Vaccination: An Interview with Elizabeth Miller. BMC Medicine, 13, 131-135.
https://doi.org/10.1186/s12916-015-0508-z
[8]
Song, G. (2014) Understanding Public Perceptions of Benefits and Risks of Childhood Vaccinations in the United States. Risk Analysis: An International Journal, 34, 541-555. https://doi.org/10.1111/risa.12114
[9]
Keelan, J., Pavri, V., Balakrishnan, R. and Wilson, K. (2010) An Analysis of the Human Papilloma Virus Vaccine Debate on MySpace Blogs. Vaccine, 28, 1535-1540. https://doi.org/10.1016/j.vaccine.2009.11.060
[10]
Gerber, J. and Offit, P. (2009) Vaccines and Autism: A Tale of Shifting Hypotheses. Clinical Infectious Diseases, 48, 456-461. https://doi.org/10.1086/596476
[11]
Morrow, E.M., Yoo, S.Y., Flavell, S.W., et al. (2008) Identifying Autism Loci and Genes by Tracing Recent Shared Ancestry. Science, 321, 218-223.
https://doi.org/10.1126/science.1157657
[12]
Kennedy, A.M., Brown, C.J. and Gust, D.A. (2005) Vaccine Beliefs of Parents Who Oppose Compulsory Vaccination. Public Health Reports, 120, 252-258.
[13]
McCormick, M.C. (2004) Immunization Safety Review: Vaccines and Autism. Institute of Medicine, Washington DC.
[14]
Nelson, K.B. and Bauman, M.L. (2003) Thimerosal and Autism? Pediatrics, 111, 674-679.
[15]
Farrington, C.P., Miller, E. and Taylor, B. (2001) MMR and Autism: Further Evidence against a Causal Association. Vaccine, 19, 3632-3625.
https://doi.org/10.1016/S0264-410X(01)00097-4
[16]
King, G.E. and Hadler, S.C. (1994) Simultaneous Administration of Childhood Vaccines: An Important Public Health Policy that Is Safe and Efficacious. The Pediatric Infectious Disease Journal, 13, 394-407.
https://doi.org/10.1097/00006454-199405000-00012
[17]
Palache, A. (2011) Seasonal Influenza Vaccine Provision in 157 Countries (2004-2009) and the Potential Influence of National Public Health Policies. Vaccine, 29, 9459-9466. https://doi.org/10.1016/j.vaccine.2011.10.030
[18]
Madsen, K.M., Hviid, A., Vestergaard, M., et al. (2002) A Population-Based Study of Measles, Mumps, and Rubella Vaccination and Autism. The New England Journal of Medicine, 347, 1477-1482. https://doi.org/10.1056/NEJMoa021134
[19]
Offit, P.A. (2008) Vaccines and Autism Revisited—The Hannah Poling Case. The New England Journal of Medicine, 358, 2089-2091.
https://doi.org/10.1056/NEJMp0802904
[20]
Dales, L., Hammer, S.J. and Smith, N.J. (2001) Time Trends in Autism and in MMR Immunization Coverage in California. JAMA, 285, 1183-1185.
https://doi.org/10.1001/jama.285.9.1183
[21]
Saleh, W.E., et al. (2017) Evaluation of Vaccine Hesitancy in Tabuk Population, Saudi Arabia. Journal of International Medical Research, 6, 22-25.
[22]
Davies, P., Chapman, S. and Leask, J. (2002) Antivaccination Activists on the World Wide Web. Archives of Disease in Childhood, 87, 22-25.
https://doi.org/10.1136/adc.87.1.22
[23]
Centers for Disease Control Prevention (1999) Thimerosal in Vaccines: A Joint Statement of the American Academy of Pediatrics and the Public Health Service. Morbidity and Mortality Weekly Report, 48, 563-565.
[24]
Baker, J.P. (2001) Mercury, Vaccines, and Autism: One Controversy, Three Histories. American Journal of Public Health, 98, 244-253.
https://doi.org/10.2105/AJPH.2007.113159
[25]
Andrews, N., Miller, E., Grant, A., Stowe, J., Osborne, V. and Taylor, B. (2004) Thimerosal Exposure in Infants and Developmental Disorders: A Retrospective Cohort Study in the United Kingdom Does Not Support a Causal Association. Pediatrics, 114, 584-591. https://doi.org/10.1542/peds.2003-1177-L
[26]
Black, S.B., Cherry, J.D., Shinefield, H.R., Fireman, B., Christenson, P. and Lampert, D. (1991) Apparent Decreased Risk of Invasive Bacterial Disease after Heterologous Childhood Immunization. The American Journal of Diseases of Children, 145, 746-749. https://doi.org/10.1001/archpedi.1991.02160070042019
[27]
Di Pasquale, A., Bonanni, P., Garçon, N., Stanberry, L., El-Hodhod, M. and Da Silva, F.T. (2017) Vaccine Safety Evaluation: Practical Aspects in Assessing Benefits and Risks. Vaccine, 34, 6672-6680. https://doi.org/10.1016/j.vaccine.2016.10.039
